$4.07
-0.13 (-2.98%)
Open$4.34
Previous Close$4.20
Day High$4.39
Day Low$4.02
52W High$6.89
52W Low$2.18
Volume—
Avg Volume537.5K
Market Cap187.37M
P/E Ratio—
EPS$-4.11
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 184.51M | 172.01M | 149.83M |
| Net Income | 6.70M | 5.27M | 5.04M |
| Profit Margin | 3.6% | 3.1% | 3.4% |
| EBITDA | 12.90M | 10.88M | 9.08M |
| Free Cash Flow | 3.45M | 3.47M | 2.49M |
| Rev Growth | +0.4% | +18.6% | +9.2% |
| Debt/Equity | 0.16 | 0.19 | 0.18 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $262.82 | +1.11% | 72.8 | 459.33B |
| AMGN | Amgen Inc | $403.04 | -1.04% | 25.1 | 219.33B |
| GILD | Gilead Sciences Inc | $144.74 | -1.87% | — | 179.15B |
| VRTX | Vertex Pharmaceuticals Inc | $504.73 | -0.40% | 30.1 | 132.51B |
| REGN | Regeneron Pharmaceuticals | $735.20 | +0.05% | 17.4 | 75.36B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.72 | -4.96% | 36.9 | 29.82B |